Answers are grounded in this paper and cite their sources.
BACKGROUND AND AIM: Postprandial reactive hypoglycaemia syndrome (PRHS) is an increasingly recognized complication after Roux-en-Y gastric bypass (RYGB) surgery. We investigated whether endoscopic ultrasound (EUS)-guided bypass reversal could provide a minimally invasive alternative to surgery in patients with severe, therapy-refractory PRHS. METHODS: We conducted a prospective pilot study in 12 patients with severe, therapy-refractory PRHS after RYGB. A 20 × 10 mm lumen-apposing metal stent (LAMS) was placed between the gastric pouch and excluded stomach. Patients were followed for 6 months with four visits and a mixed-meal test at 6 months. Primary outcomes were immediate and sustained clinical response. Secondary outcomes included technical success, quality of life assessed using a visual analogue scale (VAS), adverse events and weight change. RESULTS: Technical success was achieved in all patients. Immediate clinical response occurred in 10/12 patients (83.3%). Sustained response was observed in 7/10 patients with 6-month follow-up (70.0%; 7/8 responders). At 6 months, median VAS increased by 5.0 points (97.85% CI: 0.0-8.0) in all patients and by 6.0 points (99.22% CI: 2.0-8.0) in responders. Adverse events occurred in 2/10 patients and were moderate. One patient developed gastric discomfort and reflux; another experienced stent migration with loss of response, restored after endoscopic repositioning and fixation. Mean weight change at 6 months was -0.3 kg (95% CI: -3.89 to 3.29). CONCLUSION: In this prospective pilot study, EUS-guided gastric bypass reversal was feasible, appeared safe and was associated with a promising clinical response in severe, therapy-refractory PRHS after RYGB. Larger studies are needed to confirm these preliminary findings.
No takes yet. Share an insight, caveat, or question.
Gökce et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: